Throughout the U.S., Canada and Europe, plasma centers provide source plasma that can be manufactured into life-saving drugs and produce patient therapies, through a process called plasmapheresis. In plasmapheresis, source plasma is separated and collected from the other components of human blood. The plasma is collected from a voluntary donor and stored onsite in state-of-the-art refrigeration units until it is shipped out for fractionation. The other components of whole blood: red blood cells, white blood cells and platelets, are then returned to the body of the donor.
Modern plasma production technology remains largely based on the manufacturing process known as fractionation, in which proteins are separated to create specific therapies. Plasma protein therapies – also known as PPTs – are individualistic, biologic medicines used to treat burns, shock, trauma and a variety of diseases and disorders, including:
- life-threatening chronic and genetic issues
- bleeding disorders
- immune deficiencies
- pulmonary disorders
- neurological disorders
- shock and trauma
- liver cirrhosis
With the core plasma fractionation technology being unchanged for roughly 70 years, there is a solid foundation to the industry. Plasma cannot be synthetically manufactured or produced, so it is vital that healthy and willing volunteers continue to donate.
At Stough Group, this foundation sets the standard in our development and design of plasma centers. The designers at Barbara Stough Interiors work to create a space with donor comfort and employee safety in mind. Creating a layout that is welcoming, comfortable and clean ensures patient satisfaction and return. A space that is warm and inviting will improve a center’s productivity, boosting employee morale from the minute they step into the center to when they leave.